van Bockxmeer F M, Mamotte C D, Gibbons F A, Burke V, Taylor R R
Department of Biochemistry, Royal Perth (Australia) Hospital, Western Australia.
Circulation. 1995 Oct 15;92(8):2066-71. doi: 10.1161/01.cir.92.8.2066.
An insertion/deletion (I/D) polymorphism in the gene for angiotensin-converting enzyme (ACE) has been associated with myocardial infarction and other cardiac pathology. There is evidence for a role of the renin-angiotensin system in cell growth and in the repair of damaged arterial walls, so the ACE gene was postulated to be a candidate gene affecting the important clinical problem of restenosis after percutaneous transluminal balloon coronary angioplasty (PTCA). Because restenosis is influenced by the apolipoprotein E (apoE) genotype, the possibility of a relation between ACE and apoE genotypes and restenosis was also sought.
Subjects (< 70 years of age) were prospectively followed and had coronary angiography 6 months after PTCA to determine the presence or absence of restenosis. Those who had angiography earlier and did not have restenosis (> or = 50% loss of gain at PTCA plus > or = 50% luminal diameter stenosis) also had angiography at 6 months. The whole group (n = 207) had a higher DD genotype frequency than did 136 population control subjects (38% versus 26%, P < .02); in PTCA patients, the frequency was the same in those with and without prior myocardial infarction. The distribution of ACE genotypes was not different in the 88 patients with and 119 patients without restenosis, while the epsilon 4/4 genotype was more frequent in those with restenosis (8 of 88 versus 3 of 118, P < .05). There was no effect of the ACE genotype in noncarriers of the epsilon 4 allele, but there was a significant effect in epsilon 4 carriers (P < .005). The combined D and epsilon 4 carrier state showed a 16-fold increase in the odds ratio for restenosis (P < .02). Multiple linear regression examining the loss of lumen as a continuous variable showed significant independent effects of the ACE and apoE genotypes.
Overall, the ACE genotype had no clear influence on restenosis, but there was an interaction between ACE and apoE genotypes. The combined carrier state for the D and apoE epsilon 4 alleles substantially increased restenosis. For loss of lumen as a continuous variable, there were significant effects of both ACE and apoE genotypes. While the observations may not affect current management, they no doubt have implications in pathophysiology.
血管紧张素转换酶(ACE)基因中的插入/缺失(I/D)多态性与心肌梗死及其他心脏病变相关。有证据表明肾素-血管紧张素系统在细胞生长及受损动脉壁修复中发挥作用,因此推测ACE基因是影响经皮腔内球囊冠状动脉成形术(PTCA)后再狭窄这一重要临床问题的候选基因。由于再狭窄受载脂蛋白E(apoE)基因型影响,所以还探究了ACE与apoE基因型和再狭窄之间存在关联的可能性。
对年龄小于70岁的受试者进行前瞻性随访,并在PTCA术后6个月进行冠状动脉造影以确定有无再狭窄。那些较早进行造影且无再狭窄(PTCA时增益丧失≥50%加上管腔直径狭窄≥50%)的患者在6个月时也进行了造影。整个研究组(n = 207)的DD基因型频率高于136名人群对照受试者(38%对26%,P <.02);在PTCA患者中,有或无既往心肌梗死患者的该频率相同。88例有再狭窄患者和119例无再狭窄患者的ACE基因型分布无差异,而ε4/4基因型在有再狭窄患者中更常见(88例中有8例,118例中有3例,P <.05)。ACE基因型对ε4等位基因非携带者无影响,但对ε4携带者有显著影响(P <. 005)。D和ε4携带者联合状态使再狭窄的比值比增加了16倍(P <.02)。将管腔丧失作为连续变量进行的多元线性回归显示,ACE和apoE基因型有显著的独立影响。
总体而言,ACE基因型对再狭窄无明显影响,但ACE与apoE基因型之间存在相互作用。D和apoE ε4等位基因的联合携带者状态显著增加了再狭窄。对于管腔丧失这一连续变量,ACE和apoE基因型均有显著影响。虽然这些观察结果可能不会影响当前的治疗,但无疑对病理生理学有重要意义。